Comparative Study of Mitomycin and Lobaplatin in Advanced Colorectal Cancer Patients With Radical Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy

Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-75
SponsorUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology

About this trial

This study is a prospective, randomized, comparative clinical trial conducted by Wuhan Union Hospital and aim to compare the therapeutic effects of Mitomycin and Lobaplatin in the treatment of advanced colorectal cancer patients with radical surgery combined with hyperthermic intraperitoneal chemotherapy

Eligibility criteria

Qualifiers

No chemoradiotherapy or other anti-tumor therapy before clinical trial performed;

Aged 18-75 years;

Male or non-pregnant or lactating women;

Pathological diagnosis of colorectal adenocarcinoma;

Disqualifiers

A history of other malignant tumors within 5 years;

Distant metastasis found during surgery;

Allergic to paclitaxel, lobaplatin and other related chemotherapeutic drugs;

Suffering from epilepsy or other mental illness, unable to control behavior;

Trial design

Treatments tested in this trial

  • Mitomycin
  • Lobaplatin

Treatment groups

201 Participants
are divided into 3 treatment groups

Locations

This trial has no locations